Zhiwei Li
- Cancer Research top 0.1%
- NF-κB Signaling Pathways 17
- MicroRNA in disease regulation 10
- Cancer-related molecular mechanisms research 10
- Immunology top 0.5%
- Immune Response and Inflammation 13
- Oncology top 0.5%
- Cytokine Signaling Pathways and Interactions 9
- Molecular Biology top 0.5%
- RNA modifications and cancer 9
- Circular RNAs in diseases 7
- Cancer-related gene regulation 6
- Epidemiology top 1%
- Co-authors
- Michael KarinFlorian R. GretenYixue CaoJin Mo ParkMartin F. KagnoffTim F. GretenLars EckmannLaurence J. Egan
- Cited by
- Cancer ResearchImmunologyOncology
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Zhiwei Li
139 papers receiving 12.5k citations
Hit Papers
Peers
Comparison fields: 5 of 150
- Cancer Research 4.7k
- Immunology 3.8k
- Oncology 2.9k
- Molecular Biology 6.2k
- Epidemiology 1.7k
Countries citing papers authored by Zhiwei Li
This map shows the geographic impact of Zhiwei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiwei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiwei Li more than expected).
Fields of papers citing papers by Zhiwei Li
This network shows the impact of papers produced by Zhiwei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiwei Li. The network helps show where Zhiwei Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhiwei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 16 | |
| 6 | 2023 | 22 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 11 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 1 | |
| 12 | 2022 | 6 | |
| 13 | 2022 | 40 | |
| 14 | 2021 | 29 | |
| 15 | 2021 | 105 | |
| 16 | 2017 | 36 | |
| 17 | 2016 | 56 | |
| 18 | Synthesis and crystal structure of (2-iodo-5-nitrophenyl)-[1-(1-methylazepan-3-yl)-1H-indol-3-yl]methanones | 2013 | 1 |
| 19 | 2003 | 150 | |
| 20 | 2002 | 395 |
About Zhiwei Li
Zhiwei Li is a scholar working on Cancer Research, Immunology and Molecular Biology, having authored 148 papers that have together received 12.7k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (17 papers), Immune Response and Inflammation (13 papers), MicroRNA in disease regulation (10 papers), Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (9 papers), Cytokine Signaling Pathways and Interactions (9 papers), Circular RNAs in diseases (7 papers) and Cancer-related gene regulation (6 papers). The work is most often cited by research in Cancer Research (4.7k citations), Immunology (3.8k citations) and Oncology (2.9k citations). Zhiwei Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Michael Karin, Florian R. Greten, Yixue Cao, Jin Mo Park, Martin F. Kagnoff, Tim F. Greten, Lars Eckmann, Laurence J. Egan, Jongsoon Lee and Nicky Konstantopoulos. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.